Select the image to view the label in detail.
CJC-1295 NO DAC research profile
What is being studied?
The no-DAC listing denotes a modified hGRF(1-29)-type research material without the albumin-binding Drug Affinity Complex used in long-acting CJC-1295.
It is suited to controlled comparison with native hGRF(1-29) and DAC-modified material in receptor, stability and pituitary-cell assays. The marketed name is not a substitute for batch-level sequence confirmation.
Research areas
- GHRH-receptor activation assays
- Modified-GRF stability and sequence comparisons
- No-DAC versus albumin-binding analogue studies
Selected studies
How to read this research
These papers study defined compounds in specific experimental systems or clinical trials. They do not test or certify this product, its batch or its prepared presentation. Component and related-peptide studies do not establish the effects of a finished blend. Findings are research context, not evidence of safety or suitability for personal use. For laboratory research only; no treatment, dosing or use advice is provided.
CJC-1295 NO DAC research record
Molecular identity and stated sequence or composition, alongside the batch, storage, dispatch and document record for this 10-vial case.
Molecular identity
Supplier-designated no-DAC modified GHRH analogue
Sequence / composition
Modified hGRF(1-29) without the albumin-binding DAC group; verify against COA
Product record
The listing identifies the presentation, specification, storage record, dispatch status, and batch-document availability for the relevant product or batch.
Use restriction
For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.